News
Stockhead on MSN31m
Neurotech’s NTI164 shows excellent tolerability in key preclinical toxicology studiesNeurotech has cleared a key safety hurdle for its lead drug NTI164, with new toxicology results paving the way for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback